Dongwei Dou

1.2k total citations
16 papers, 518 citations indexed

About

Dongwei Dou is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Dongwei Dou has authored 16 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Dongwei Dou's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (4 papers). Dongwei Dou is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (4 papers). Dongwei Dou collaborates with scholars based in China. Dongwei Dou's co-authors include Xinxing Wang, Xiaodong Xu, Mingli Han, Xin Ge, Yuanting Gu, Guangcheng Guo, Xiaoyang Ren, Xueke Qian, Xinhong Pei and Zhe Zhang and has published in prestigious journals such as Journal of Cellular Physiology, Molecular Therapy and Journal of Cellular Biochemistry.

In The Last Decade

Dongwei Dou

16 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dongwei Dou China	13	431	355	73	39	36	16	518
Shentong Yu China	8	452 1.0×	342 1.0×	73 1.0×	22 0.6×	29 0.8×	11	524
Yin‐Ling Xiu China	15	513 1.2×	427 1.2×	69 0.9×	42 1.1×	24 0.7×	23	626
Jennifer F. Barger United States	7	469 1.1×	358 1.0×	67 0.9×	44 1.1×	37 1.0×	8	567
Xianghong Yang China	13	274 0.6×	208 0.6×	99 1.4×	43 1.1×	29 0.8×	24	371
Shi Huirong China	10	468 1.1×	426 1.2×	48 0.7×	37 0.9×	31 0.9×	32	593
Kulsoom Junejo Qatar	8	304 0.7×	227 0.6×	120 1.6×	34 0.9×	37 1.0×	13	422
Qiqi Shi China	9	322 0.7×	161 0.5×	89 1.2×	57 1.5×	34 0.9×	16	458
Ana Lameirinhas Portugal	12	269 0.6×	188 0.5×	72 1.0×	25 0.6×	54 1.5×	18	386
Liutao Chen China	7	445 1.0×	230 0.6×	51 0.7×	24 0.6×	38 1.1×	7	511

Countries citing papers authored by Dongwei Dou

Since Specialization

Citations

This map shows the geographic impact of Dongwei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Dou more than expected).

Fields of papers citing papers by Dongwei Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongwei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Dou. The network helps show where Dongwei Dou may publish in the future.

Co-authorship network of co-authors of Dongwei Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Dongwei Dou. A scholar is included among the top collaborators of Dongwei Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongwei Dou. Dongwei Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Xu, Xiaodong, Xinxing Wang, Dongwei Dou, et al.. (2021). miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome. Cell Death and Disease. 12(4). 350–350. 21 indexed citations

Wang, Xinxing, et al.. (2021). Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer. Cell Death and Disease. 12(5). 412–412. 29 indexed citations

Wang, Xinxing, Yujie Zhang, Xinhong Pei, et al.. (2020). TRIM3 inhibits P53 signaling in breast cancer cells. Cancer Cell International. 20(1). 559–559. 16 indexed citations

Ren, Xiaoyang, et al.. (2020). The Application of Mobile Telehealth System to Facilitate Patient Information Presentation and Case Discussion. Telemedicine Journal and e-Health. 26(6). 725–733. 17 indexed citations

Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell International. 20(1). 454–454. 79 indexed citations

Han, Mingli, Xueke Qian, Hui Cao, et al.. (2020). lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy. Molecular Therapy. 28(11). 2488–2502. 44 indexed citations

Wang, Xinxing, Xinhong Pei, Guangcheng Guo, et al.. (2020). Exosome‐mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer. Journal of Cellular Physiology. 235(10). 6896–6904. 94 indexed citations

Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axis. Molecular Oncology. 15(2). 697–709. 53 indexed citations

Ge, Xin, et al.. (2019). NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer. Journal of Cellular Physiology. 234(12). 23409–23420. 24 indexed citations

10.

Dou, Dongwei, Xin Ge, Xinxing Wang, et al.. (2019). <p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>. OncoTargets and Therapy. Volume 12. 9627–9637. 29 indexed citations

11.

Han, Mingli, Yimeng Wang, Yuanting Gu, et al.. (2019). lncRNA GHET1 knockdown suppresses breast cancer activity in vitro and in vivo.. PubMed. 11(1). 31–44. 11 indexed citations

12.

Han, Mingli, Yimeng Wang, Li Lin, et al.. (2018). microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. Journal of Cellular Biochemistry. 119(10). 8138–8145. 35 indexed citations

13.

Wang, Xinxing, Guangcheng Guo, Xueke Qian, et al.. (2018). miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3. Cancer Cell International. 18(1). 171–171. 29 indexed citations

14.

Li, Jiatong, Dongwei Dou, Ping Li, et al.. (2017). PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population. Tumor Biology. 39(7). 3726132291–3726132291. 12 indexed citations

15.

Tan, Jun, Dongwei Dou, Chen Ding, et al.. (2016). Effect of Kruppel-like factor 4 on Notch pathway in hepatic stellate cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(6). 811–816. 4 indexed citations

16.

Liu, Kun, Yuening Zhang, Chengdong Zhang, et al.. (2016). Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget. 7(35). 56798–56810. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact